Devices and methods for non-invasive implant length sensing

Information

  • Patent Grant
  • 11445939
  • Patent Number
    11,445,939
  • Date Filed
    Wednesday, July 8, 2020
    3 years ago
  • Date Issued
    Tuesday, September 20, 2022
    a year ago
Abstract
A device for the non-invasive sensing of the length of an implantable medical device includes an implantable medical device having first and second portions moveable relative to one another and a layer of resistive material disposed on one of the first and second portions. A contact is disposed on the other of the first and second portions, the contact being in sliding contact with the layer of resistive material upon relative movement between the first and second portions. A circuit is configured to measure the electrical resistance along a path including a variable length region of the layer of resistive material and the contact. The electrical resistance can then be converted into a length.
Description
FIELD OF THE INVENTION

The field of the invention generally relates to implantable medical devices and more particularly, implantable medical devices that undergo changes in length.


BACKGROUND

A variety of medical devices exist that are implanted inside the body and undergo a dimensional change. For example, a bone lengthening device is one type of implantable device that is typically inserted into first and second portions of a severed or broken bone. The device is then periodically lengthened to distract or grow the bone over a period of time. Such adjustments made to the bone lengthening device may be invasive or even non-invasive. As another example, growing rods or distraction devices may be secured to a subject's spine. These devices may be used to correct a medical condition such as scoliosis. In still other applications, these devices may be used to increase the distance between adjacent vertebrae to reduce symptoms associated with lumbar spinal stenosis or pinched nerves. Other bones such as the jaw bone may include an implantable medical device that is configured to elongate over time.


Regardless of the nature in which the implanted medical device is used, there often is a need to determine the absolute length of the implant as it exists inside the patient at any given moment. As an example, after the implanted medical device has undergone a length adjustment there is a need to determine whether or not the desired quantity of lengthening was indeed achieved. In addition, devices may change dimensions after the adjustment has been made (whether manual or non-invasive). For example, normal physiological movement of the subject may cause additional shortening or lengthening of the device after adjustment of the device. In these instances, it would be beneficial to know the actual length of the device in between adjustment procedures. For example, a physician might want to know if the device has strayed too far in either direction to warrant an additional adjustment.


U.S. Patent Application Publication No. 2010/0094302 discloses a non-invasive medical implant device that uses microphone sensor on an external adjustment device to sense when an internally-located magnet is undergoing rotation. Specifically, the microphone sensor picks up an acoustic signal (e.g., click) that is periodically generated by rotation of an internal magnet that is part of the implantable medical device. By counting the number of clicks, the external adjustment device can then translate this into an estimated length of the device. While such a method does provide a means to determine the length of the implanted medical device there is the possibility that one or more of the click signals may not be detected by the external adjustment device. In this instance, the actual length of the implanted medical device may then be different from the length that is calculated or otherwise determined by the external adjustment device. Further, while the external adjustment device may store the most current length of the device as determined by the sensed signals, it is possible that the subject may return to a different physician for his or her next adjustment procedure. Unless the size of the implanted medical device is stored locally on or with the patient (e.g., RFID or a card carried by the patient), the next physician will not know the most recent sizing of the device. Moreover, as stated above, there is the possibility that the implanted device may change lengths in between adjustment procedures. There thus is a need for methods and devices that will determine the absolute length of an implantable medical device at any given movement.


SUMMARY

In one embodiment of the invention, a device includes an implantable medical device having first and second portions moveable relative to one another and a layer of resistive material disposed on one of the first and second portions. The device includes a contact disposed on the other of the first and second portions, the contact being in sliding contact with the layer of resistive material upon relative movement between the first and second portions and a circuit configured to measure the electrical resistance along a path including a variable length region of the layer of resistive material and the contact.


In another embodiment of the invention, a method of sensing the length of an implantable medical device having first and second portions moveable relative to one another is disclosed. The implantable medical device includes a resistive pathway on one of the first and second portions of the implantable medical device along with a contact disposed on the other of the first and second portions, the contact being in sliding contact with the resistive pathway upon relative movement between the first and second portion. The electrical resistance along a path including a variable length region of the resistive pathway and the contact is measured. The measured electrical resistance is then converted to a length.


In another embodiment, a device includes an implantable medical device having first and second portions moveable relative to one another and a primary drive coil surrounding a segment of the implantable medical device containing both the first and second portions. At least one secondary coil surrounds a segment of the implantable medical device containing both the first and second portions. The device includes a first circuit configured to apply a drive voltage to the primary drive coil and measure signals in the at least one secondary coil and output a signal indicative to the length of the implantable medical device.


In another embodiment, a method of sensing the length of an implantable medical device having first and second portions moveable relative to one another includes applying a driving voltage to a primary drive coil surrounding a segment of the implantable medical device containing both the first and second portions. Signals in at least one secondary coil surrounding a segment of the implantable medical device containing both the first and second portions are measured and converted to a length.


In another embodiment, a device includes an implantable medical device having first and second portions moveable relative to one another, wherein the first and second portions are separated from one another by a dielectric material. The device includes an implantable resonant coil coupled to the first and second portions and an externally located drive coil operatively coupled to a signal generator. A frequency analyzer is operatively coupled to the drive coil configured to detect the resonant frequency of the implantable medical device, wherein said resonant frequency varies depending on the degree of relative orientation between the first and second portions.


In another embodiment a method of sensing the length of an implantable medical device having first and second portions moveable relative to one another includes providing an implantable medical device wherein the first and second portions are coupled to an implanted resonant coil. An external drive coil is driven adjacent to the implanted resonant coil with a signal generator at different frequencies. A resonant frequency of the implantable medical device is detected and the resonant frequency of the implantable medical device is converted to a length.


In another embodiment, a device includes an implantable medical device having first and second portions moveable relative to one another and an elongate member having first and second ends, the first end being secured to the first portion of the implantable medical device, the second end having secured thereto a magnet. The device includes a fulcrum on the second portion of the implantable medical device and contacts various points along the elongate member in response to relative movement of the second member relative to the first member. An externally located magnetic field source is configured to apply an oscillating magnetic field in proximity to the magnet secured to the elongate member.


In another embodiment, a method of sensing the length of an implantable medical device includes providing an implantable medical device having first and second portions moveable relative to one another, an elongate member having first and second ends, the first end being secured to the first portion of the implantable medical device, the second end having secured thereto a magnet, and a fulcrum on the second portion of the implantable medical device and in contact with various points along the elongate member in response to relative movement of the second member relative to the first member. An oscillating magnetic field is applied at different frequencies in proximity to the magnet with an externally located magnetic field source driven by a power source. The power source for the externally located magnetic field source is monitored wherein the resonant frequency of the elongate member is determined based at least in part on the current draw of the power source. The resonant frequency of the elongate member is then converted to a length.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1A illustrates a device that non-invasively measures the length of an implantable medical device according to one embodiment.



FIG. 1B illustrates a full sectional view of the device of FIG. 1A taken along the line A-A.



FIG. 1C illustrates view B of FIG. 1B.



FIG. 1D illustrates a calibration curve for the device of FIGS. 1A-1C.



FIG. 2A illustrates a perspective view of an external adjustment device.



FIG. 2B illustrates a perspective view of an external adjustment device according to another embodiment.



FIG. 3A illustrates a device that non-invasively measures the length of an implantable medical device according to another embodiment.



FIG. 3B illustrates a calibration curve for the device of FIG. 3A.



FIG. 4A illustrates a device that non-invasively measures the length of an implantable medical device according to another embodiment.



FIG. 4B illustrates a calibration curve for the device of FIG. 4A.



FIG. 4C illustrates another embodiment of the device of FIG. 4A.



FIG. 5A illustrates a device that non-invasively measures the length of an implantable medical device according to another embodiment.



FIG. 5B illustrates an enlarged view showing the rod and fulcrum that interfaces with the elongate member having a magnet disposed on an end thereof.



FIG. 5C illustrates a cross-sectional view taken along the line B-B of FIG. 5B.



FIG. 5D illustrates a motor driven external magnet for use with the device of FIG. 5A.



FIG. 5E illustrates an external electromagnet for use with the device of FIG. 5A.



FIG. 5F illustrates a calibration curve for the device of FIG. 5A.





DETAILED DESCRIPTION OF THE ILLUSTRATED EMBODIMENTS


FIG. 1A illustrates a device 10 that non-invasively measures the length of an implantable medical device 12. The implantable medical device 12 may include any number of implantable medical devices 12 including those used to lengthen or distract bone or other tissue. These include, by way of example, distraction devices for use in bone lengthening applications (e.g., limb lengthening), spinal distraction devices for the treatment of scoliosis, spinal devices for the treatment of lumbar spinal stenosis, dental devices, and the like. The implantable medical device 12 may be one that is adjusted manually or more preferably, non-invasively. Still referring to FIG. 1A, the implantable medical device includes a first portion 14 and a second portion 16 that are moveable relative to one another. During use, the first portion 14 and second portion 16 move apart from one another for distraction or lengthening. Conversely, the first portion 14 and the second portion 16 may move toward one another for adjustment purposes or even to reduce lengthening or distraction forces. As seen in FIGS. 1A-1C, the first and second portions 14, 16 move in a telescopic fashion. In other alternative embodiments, however, the first and second portions 14, 16 do not need to be fashioned to move relative to one another in a telescopic manner. During implantation, the first portion 14 is typically secured to a first location (e.g., bone) while the second portion 16 is secured to a second, different location (e.g., different bone). Various fixation devices such as screws, pins, hooks, articulating joints, and the like may be used to secure one or both ends of the first and second portions 14, 16. In other embodiments, such as limb lengthening applications, a cavity, which may be natural or formed inside the bone, is used to receive one or both of the first and second portions 14, 16. The first and second portions 14, 16 may be secured using a mechanical fastener, cement, or method commonly known to those skilled in the art.


In the embodiment illustrated in FIGS. 1A-1C, the first portion 14 is a housing 18 in the shape of a tube or the like and is made from a biocompatible metal such as titanium. The housing 18 includes therein a permanent magnet 20 that is configured for rotational movement relative to the housing 18. The permanent magnet 20 may be formed from a rare earth magnet such as Neodymium-Iron-Boron. The permanent magnet may be made from a grade of N35 or higher, for example a grade of N50. One or more bearings 22 may be used to retain the permanent magnet 20. A lead screw 24 is connected either directly or indirectly via gears or the like (not shown) to the permanent magnet 20. Thus, rotational movement of the permanent magnet 20 causes rotational movement of the lead screw 24.


The second portion 16 of the implantable medical device 12 is in the form of a rod 26 that includes a hollow segment 28 that is dimensioned to receive the lead screw 24. A nut 30 is located within the hollow segment 28 and has threading that interfaces with threads located on the lead screw 24. Rotation of the lead screw 24 in a first direction thus causes the rod 26 to telescope into the housing 18 thus shortening the overall length of the implantable medical device 12. Conversely, rotation of the lead screw 24 in a second, opposite direction causes the rod 26 to telescope out of the housing 18 thus lengthening the overall length of the implantable medical device 12. A seal 32 is provided between the rod 26 and the housing 18 such that fluids and material remain external to the rod 26 and housing 18 during movement.


Rotation of the permanent magnet 20 is accomplished by application of a moving magnetic field from a location external to the subject having the implantable medical device. The moving magnetic field is typically applied using an external adjustment device that has one or more rotating magnets that generate the driving magnetic field. Particular details on the nature of the external adjustment devices that can be used in connection with the distraction devices described herein are disclosed, for example, in U.S. Patent Application Publication Nos. 2009/0112207, 2010/0094302, 2010/0121323, and U.S. patent application Ser. No. 13/172,598, all of which are incorporated by reference herein. FIG. 2A illustrates an external adjustment device 400 according to one embodiment that includes two permanent magnets 402, 404 contained within respective covers 406. Each permanent magnet 402, 404 is rotatable within its respective cover 406 and provides a moving magnetic field. A motor 408 is mechanically engaged to the permanent magnets 402, 404 via a transmission (not shown) contained within a housing 410 of the external adjustment device 400. FIG. 2B illustrates another embodiment of an external adjustment device 700. The external adjustment device includes a first handle 702 and a second handle 704. Like the prior embodiment, there are two permanent magnets 706, 708 that are rotatable and provide a moving magnetic field. A power cord 711 supplies power to a motor 705 that drives the permanent magnets 706, 708 via a gear box (not shown). Additional details regarding external adjustment device 700 may be found in U.S. application Ser. No. 13/172,598 which is incorporated by reference herein.


Referring back to FIGS. 1A-1C, the housing 18 includes a layer of resistive material 36 on an inner surface thereof. As best seen in FIGS. 1A and 1B, the housing 18 includes two separate layers of the resistive material 36 on generally opposing interior surfaces of the housing 18. It should be understood, however, that a single layer of resistive material 36 may suffice. Similarly, there may be more than two layers of resistive material 36. The layer of resistive material 36 may include any number of materials known to have a degree of electrical resistance. Exemplary materials include, for example, carbon although other known electrically resistive materials will work. Generally, in order to increase the resolution of the device 10, the resistive material 36 should have a relatively high degree of electrical resistance so that small changes in length will correspond to larger resistance differentials. An electrically conductive contact 38 is secured to the end of the rod 26. The contact 38 thus moves in conjunction with the rod 26 upon actuation of the permanent magnet 20. The contact 38 includes contact surfaces 40 that physically touch the resistive material 36. The contact surfaces 40 may include an edge, brushes, or rollers that contact the layer of resistive material 36. In this regard, the contact 38 forms part of the electrical circuit for measuring the resistance of the implantable medical device 12. Depending on the location of the rod 26, the actual length of the resistive material 36 within the electrical circuit varies. Thus, when the rod 26 is extended outward with respect to the housing 18 a larger portion of the resistive material 36 is part of the resistance circuit and resistance measurements via the circuit (discussed below in more detail) are higher. Conversely, when the rod 26 is collapsed inside the housing 18 a smaller portion of the resistive material 36 is part of the resistance circuit and resistance measurements via the circuit are lower. The contact 38 includes an aperture 42 therein for passage of the lead screw 24.


As seen in FIG. 1A, electrical conductors 44, 46 electrically connect to the two respective layers of resistive material 36. These electrical conductors 44, 46 connect to a circuit 48 which may be implemented in a microprocessor or the like. For example, the circuit 48 may include one or more processors configured to read and process measured resistance values at points a and b of the circuit in FIG. 1A. The circuit 48 may also optionally include memory for storing data therein. The memory may comprise an RFID chip. The data may include, for example, resistance values or corresponding data as well as calibration data unique to the particular implantable medical device 12. The circuit 48 is coupled to an antenna 50 which enables the circuit 48 to transmit data and other information to an externally located controller 52. The externally located controller 52 includes an antenna 54 and acts as a receiver to receive data communicated from the circuit 48. Thus, the circuit 48 acts as a transmitter while the controller 52 acts as a receiver. In one aspect of the invention, the controller 52 both powers and communicates digitally with the circuit 48. In this regard the circuit 48 does not need its own power source as the circuit 48 is powered inductively via the external controller 52. As seen in FIG. 1A, the communication occurs across the skin 56 of the subject.


The controller 52 includes a display 58 that is used to display one or more parameters indicative of the length of the implantable medical device 12. This can include a numerical value corresponding to the absolute length of the implantable medical device 12. The display 58 may also include a graphical representation of the device length (e.g., bar graph or the like) or other indicia of length. The controller 52 may also display the resistance value measured by the circuit 48.



FIG. 1B illustrates an optional feature wherein a plurality of longitudinal grooves 60 are disposed along an inner surface of the housing 18. The rod 26 includes corresponding protrusions (not shown) that form a splined tip that interfaces with the corresponding grooves 60. The tight tolerance of the splined tip with the grooves 60 keeps the rod 26 centered within the housing 18. Further, the combination of the splined tip and the grooves 60 act as an anti-rotation feature that prevents the rod 26 from rotating relative to the housing 18. Additional details regarding this optional aspect may be found in U.S. Patent Application Publication No. 2010/0217271 which is incorporated herein by reference.



FIG. 1C illustrates an enlarged view of detail B of FIG. 1B. As seen in FIG. 1C, the layer of resistive material 36 may be disposed on an insulation layer 62. The insulation layer 62 electrically insulates the layer of resistive material 36 from the underlying metallic housing 18. The insulation layer 62 may include a thin oxide layer that is formed by anodization.


To use the device 10, the external adjustment device 400 is placed near or adjacent to the patient's skin 56 near the location of implantable medical device 12. Activation of the external adjustment device 400 causes the two permanent magnets 402, 404 to rotate thereby causing the permanent magnet 20 to rotate along with the lead screw 24. Depending on the direction of rotation, the rod 26 either extends from or retracts into the housing 18. The actual length of the implantable medical device 12 is determined by measuring the resistance at points a and b using the circuit 48. The resistance measured at points a and b varies depending on the position of the contact 38 on the layer of resistive material 36. As the contact 38 moves away from the permanent magnet 20 additional resistance is added to the electrical pathway because of the additional resistive material 36 that is present in the electrical circuit. The circuit 48 measures this resistance value wherein it can be stored in the circuit 48 for later transmission or, alternatively, the resistance value may be directly transmitted to the controller 52. For example, in one aspect of the invention, when the circuit 48 is powered inductively via the external controller 52, one or more resistance measurements are made by the circuit 48 and this information is then transmitted wirelessly to the controller 52. The controller 52 can then take this data (e.g., resistance data) and convert the same to a length. For example, the controller 52 may include calibration data (calibration curve, look-up table, or the like) that is used to translate a resistance value into a length. The length can then be displayed on the display 58. The calibration data may be communicated from the circuit 48 or it may have already been pre-loaded into the controller 52. In addition, it is possible that the circuit 48 itself translates the resistance reading into a length and data corresponding to a length is transmitted to the controller 52.



FIG. 1D illustrates an illustrative calibration curve for the device of FIGS. 1A-1C. As seen in FIG. 1D, an increased resistance corresponds to an increased length of the implantable medical device 12. The calibration curve may be used for a number of different implantable medical devices 12 or it may be tailored to a single implantable medical device 12. In the example of FIG. 1D, a reading of 146 Ω corresponds to a length of 25.0 mm. Once this conversion has been made the length of 25.0 mm can then be displayed on the display 58 of the controller 52.



FIG. 3A illustrates an alternative embodiment of a device 70 that non-invasively measures the length of an implantable medical device 72. The implantable medical device 72 includes a first portion 14 and a second portion 16 that are moveable relative to one another. Those aspects of this embodiment of the implantable medical device 72 that are common with the embodiment of FIGS. 1A-1C are labeled with the same element numbers and will not be described again. In this embodiment, the magnetic coupling between coils is used to measure the length of the implantable medical device 72. In a similar manner to a linear variable differential transformer (LVDT) a primary coil 74 circumscribes the housing 18 and is coupled to a drive circuit 76 that delivers alternating current through the primary coil 74. A secondary coil 78 or multiple secondary coils connected in reverse series also surround the housing 18 and are coupled to a sensing circuit 80 which may be the same as or different from the drive circuit 76. The output signal from the secondary coil(s) 78, which is typically a voltage, is generally proportional to the distance moved by the rod 26 within the housing 18. The location of the primary coil 74 and the secondary coil 78 is such that the coils 74, 78 generally circumscribe the region of overlap between the rod 26 and the housing 18. By measuring the output signal with the secondary coil(s) 78, this value can then be translated into a length of the implantable medical device 72.


The sensed or decoded signal received from the secondary coil(s) 78 is then passed to a telemetry circuit 82. The telemetry circuit 82 wirelessly transmits data through the skin 56 via an antenna 84 to an external controller 86. The external controller 86 is includes an antenna 88 and acts as a receiver to receive data communicated from the telemetry circuit 82. Thus, the telemetry circuit 82 acts as a transmitter while the controller 86 acts as a receiver. In one aspect of the invention, the controller 86 both powers and communicates digitally with the telemetry circuit 82. The controller 86 may also power the sensing circuit 80. In this regard the circuits 80, 82 do not need their own power source as the circuits 80, 82 are powered inductively via the external controller 86. As seen in FIG. 3A, the communication occurs across the skin 56 of the subject.


The controller 86, like the controller 52 of the earlier mentioned embodiment, has a display 90 that is used to display length information to a user. In one aspect of the invention, the controller 86 converts the data transmitted by the telemetry circuit 82, which may be voltage data, into length data. The controller 86 may do this by using calibration data that relates the degree of magnetic coupling (e.g., voltage output) to a length. FIG. 3B illustrates an example of a calibration that relates output (voltage) as a function of length. This calibration data may be stored in the controller 86 or transmitted from the telemetry circuit 82. Alternatively, the conversion from magnetic coupling to length can be done by the sensing circuit 80. Regardless of where the conversion is made, once a length is determined, the value can be presented to the user on the display 90.


In this embodiment, the rod 26 acts as a core that affects the degree of magnetic coupling between the primary coil 74 and the secondary coil 78. The rod 26 is preferably made from a material with a relatively high degree of magnetic permeability. This may include metals or alloys of metals. The material should also be biocompatible. Titanium and titanium alloys have excellent biocompatibility and marginal magnetic permeability. To improve on the efficiency of the resulting LVDT, a rod material with a higher magnetic permeability, such as stainless steel or other iron containing materials may be used. If a titanium or titanium alloy rod is desirable, an additional core component with higher magnetic permeability may be attached to the rod. For example a tube may be secured over the outer diameter or within an inner diameter of the rod 26. Alternatively, the nut 30 may be made from a material with higher magnetic permeability than titanium, and thus improve the effect of the core. Generally, the higher degree of magnetic permeability should translate into a device 70 with more sensitivity because an incremental movement of the rod 26 relative to the housing 18 will results in a larger change in magnetic coupling. That is to say, in the context of the calibration curve of FIG. 3B, for a given change in length, a higher degree of magnetic permeability would translate into a larger change in voltage output.



FIG. 4A illustrates another alternative embodiment of a device 100 that non-invasively measures the length of an implantable medical device 102. The implantable medical device 102 includes a first portion 14 and a second portion 16 that are moveable relative to one another. Those aspects of this embodiment of the implantable medical device 102 that are common with the embodiment of FIGS. 1A-1C are labeled with the same element numbers and will not be described again. In this device 100, a resonant coil 104 is electrically coupled to the housing 18 and the rod 26 via electrical conductors 106, 108. The electrical conductors 106, 108 may include wires, electrical traces in a printed circuit board, or the like. The rod 26 and the housing 18 are electrically isolated from one another. Electrical isolation may be accomplished by preventing the physical touching of the two components. In addition, electrical isolation may be achieved by coating one or both of the rod 26 and housing 18 with a dielectric material. This will isolate the rod 26 from the housing 18 and create a variable capacitor. A dielectric layer 27 between the rod 26 and housing 18 forms a capacitor that varies as the rod 26 moves in and out of the housing 18. The movement of the rod 26 changes the surface area of overlap between the rod and the housing thus changing the capacitance as a function of implant length. When the rod is fully retracted, the capacitance is maximized. When the rod is fully extended, the capacitance is minimized. The dielectric layer 27 may consist of a thin Kapton® (polyimide) tube bonded to the inner diameter of the housing 18, although other dielectric materials may be used (e.g., a gas such as air). Thus, the dielectric layer 27 may be applied as a layer or coating on either the rod 26 or the housing 18 (or both). Alternatively, the dielectric layer 27 may be a gap between the rod 26 and the housing 18 that is filled with air. The resonant coil 104 connected to the capacitor acts as an inductor, creating a resonant LC circuit. The device 100 further includes a drive coil 110 that is coupled to a signal generator 112. The drive coil 110 and signal generator 112 are located external to the subject with the implantable medical device 102 as illustrated in FIG. 4A. The signal generator 112 generates an alternating current (AC) signal that delivered to the drive coil 110. The drive coil 110 is located near or adjacent to the skin 56 of the subject at a location that is near or adjacent to the resonant coil 104. The resonant coil 104 may be located at a location remote from implantable medical device 102 (e.g., near the surface of the skin 56). The signal generator 112 preferably has the ability to deliver AC signals to the drive coil 110 at a variety of frequencies via input 114. The device 100 further includes a frequency analyzer 116 which may take the form of an oscilloscope or the like. The frequency analyzer 116 is used to determine when the resonant frequency of the implantable medical device 102 has been reached. In particular, the frequency of the applied AC signal is adjusted via the signal generator 112 until the frequency analyzer 116 detects that the resonant frequency has been reached. The frequency range sweep by the signal generator 112 may be automated or even manual. Detection is made when the amplitude of the signal detected by the frequency analyzer 116 drops or dips significantly. This may be detected automatically by the frequency analyzer 116. The user will thus know the resonant frequency of the implantable medical device 102 which can then be converted to a length. The particular resonant frequency of the implantable medical device 102 varies as a function of the length. A calibration curve that includes the resonant frequency of the implantable medical device 102 as a function of length can then be used determine the absolute length of the implantable medical device 102. In this regard, once the user knows the resonant frequency, the corresponding length value can be determined using the calibration curve. This can be done manually or it could be automated using a processor or computer that translates the measured resonant frequency into a length value. The frequency analyzer 116 may be separate from the signal generator 112 as seen in FIG. 4A, however, in other embodiments these two components may be integrated into a single external device as seen in FIG. 4C.


Table 1 listed below illustrates data obtained generating a calibration curve of an implantable medical device 102. Data was obtained by varying the length of the implantable medical device 102 in ¼ inch increments and adjusting the frequency of the signal generator 112 until the resonant frequency was observed with the frequency analyzer 116. In the tested device, 0.0025 inch KAPTON® polyimide tape was wrapped around the rod 26 to isolate it from the housing 18 and act as a dielectric. As noted above, the resonant frequency was determined based on a dip of the amplitude of the signal measured by the frequency analyzer 116.












TABLE 1







Distraction
Resonant



(inches)
Frequency (kHz)



















0
104.016



.25
110.083



.50
116.780



.75
123.887



1.00
133.136



1.25
141.557



1.50
153.635



1.75
168.469



2.00
190.366











FIG. 4B illustrates the data of Table 1 plotted as a calibration curve showing distraction length as function of resonant frequency. In this embodiment, once the resonant frequency is determined, one can then readily determine the distraction length based on the calibration curve. The calibration curve may be unique to the implantable medical device 102 and may be provided with the same or the calibration curve can be developed by the physician. Again, this method enables the physician or other skilled person to determine the absolute length of the implantable medical device 102 by non-invasive interrogation.



FIGS. 5A-5E illustrate another alternative embodiment of a device 110 that non-invasively measures the length of an implantable medical device 112. The implantable medical device 112 includes a first portion 14 and a second portion 16 that are moveable relative to one another. Those aspects of this embodiment of the implantable medical device 102 that are common with the embodiment of FIGS. 1A-1C are labeled with the same element numbers and will not be described again. As best seen in FIGS. 5A and 5B, an elongate member 114 is disposed inside the housing 18 and is affixed to the housing 18 at one end thereof. On the opposing end of the elongate member 114 is located a permanent magnet 116 (best seen in FIG. 5B). The elongate member 114 passes through a fulcrum 118 that is fixedly attached to the rod 26. As best seen in FIGS. 5B and 5C, the fulcrum 118 may include a projection 120 extending from the rod 26 that includes an aperture 122 dimensioned to permit the fulcrum 118 to slide along the length of the elongate member 114 as the rod 26 is moved relative to the housing 18. In this regard, the fulcrum 118 adjusts the length of the elongate member 114 between the magnet 116 and the fulcrum 118. By changing this length, the natural vibrational frequency of the elongate member 114 changes.


As part of the device 110, an externally located magnetic field source 124 is provided that applies an oscillating magnetic field to the implantable medical device 112. The oscillating magnetic field passes through the skin 56 of the subject and interacts with the magnet 116 disposed on the end of the elongate member 114. During use, the frequency of the oscillating magnetic field is adjusted (e.g., step wise adjustment) until the resonant frequency of the elongate member 114 is reached. At the resonant frequency, the magnet 116 and attached elongate member 114 vibrate back-and-forth as illustrated by arrow A of FIG. 5B. This vibration can be detected by the power that is supplied to magnetic field source 124. In one aspect, as seen in FIG. 5D, the magnetic field source 124 is a permanent magnet 125 that is rotated by a motor 126 that is powered by a driving circuit 128. The driving circuit 128 is capable of adjusting the rotational frequency of the motor 126 and thus the magnet 125. The driving circuit 128 is also able to monitor the current that drives the motor 126 using current sense circuitry. The resonant frequency is detected when a current spike is observed in the driving circuit 128. The frequency of the oscillating magnetic field can then be converted to a device length by using a calibration curve that relates length of the device to the rotational frequency of the oscillating magnetic field. FIG. 5F illustrates an exemplary calibration curve of the resonant frequency as a function of length for the device 110. The length of the device 110 may be determined by examining where the resonant frequency intersects with the calibration curve. As with all the calibration curves described herein, this may be done as a look-up table, function, or other method commonly known to those skilled in the art. As an alternative to the use of the motor 126, FIG. 5E illustrates an alternative embodiment that uses an electromagnet 130 that is driven by a driving circuit 128. Driving current can be measured by current sense circuitry in the driving circuit 128.


While embodiments have been shown and described, various modifications may be made without departing from the scope of the inventive concepts disclosed herein. For example, while the devices described in detail herein are driven non-invasively, the methods and devices are also applicable to implantable medical device that are adjusted manually. Similarly, while embodiments described in detail herein utilize a magnet coupled to a lead screw to adjust the length of an implantable medical device other drive devices may fall within the scope of the invention. Moreover, only a portion of the implantable medical device may change length or shape and be measured in a non-invasive manner. The invention(s), therefore, should not be limited, except to the following claims, and their equivalents.

Claims
  • 1. A device comprising: an implantable medical device having a first portion and a second portion that are telescopically moveable relative to one another,wherein the first portion includes a housing having a first closed end configured to be secured to a first portion of a bone and a second open end opposite the first closed end, a first permanent magnet within the housing, and a lead screw within the housing that extends along a central axis of the housing and is rotatably secured to the first permanent magnet,wherein the first permanent magnet is configured to receive an oscillating magnetic field from an external source to rotate the lead screw non-invasively,wherein the second portion includes a rod having a first closed end configured to be secured to a second portion of the bone, a hollow segment dimensioned to receive the lead screw, and a second open end opposite to the first closed end of the rod having a threaded nut configured to engage the lead screw within the hollow segment,wherein the first portion is configured to telescopically move relative to the second portion by rotating the lead screw;an elongate member disposed within the housing of the first portion of the implantable medical device along a longitudinal axis offset from the central axis of the housing, the elongate member including a first end secured to the housing adjacent to the first permanent magnet and a second end secured to a second permanent magnet opposite the first end; anda fulcrum coupled to the rod of the second portion of the implantable medical device, the fulcrum including a projection that extends radially from the rod, and an aperture in the projection that is dimensioned to permit the fulcrum to slide along a length of the elongate member extending therethrough in response to relative telescopic movement of the second portion relative to the first portion.
  • 2. The device of claim 1, further comprising: an externally located magnetic field source, the externally located magnetic field source configured to apply an oscillating magnetic field in proximity to the second permanent magnet secured to the elongate member.
  • 3. The device of claim 2, wherein the externally located magnetic field source comprises an electromagnet.
  • 4. The device of claim 3, further comprising current sense circuitry operatively coupled to the electromagnet.
  • 5. The device of claim 2, wherein the externally located magnetic field source comprises a rotatable permanent magnet operatively connected to a motor.
  • 6. The device of claim 5, further comprising current sense circuitry operatively coupled to the motor.
US Referenced Citations (527)
Number Name Date Kind
2702031 Wenger Feb 1955 A
3111945 Von Solbrig Nov 1963 A
3372476 Pfeiffer Mar 1968 A
3377576 Langberg Apr 1968 A
3512901 Law May 1970 A
3597781 Eibes Aug 1971 A
3900025 Barnes, Jr. Aug 1975 A
3915151 Kraus Oct 1975 A
RE28907 Eibes et al. Jul 1976 E
3976060 Hildebrandt et al. Aug 1976 A
4010758 Rockland et al. Mar 1977 A
4056743 Clifford et al. Nov 1977 A
4062354 Lyndon Dec 1977 A
4068821 Morrison Jan 1978 A
4078559 Nissinen Mar 1978 A
4204541 Kapitanov May 1980 A
4357946 Dutcher et al. Nov 1982 A
4386603 Mayfield Jun 1983 A
4448191 Rodnyansky et al. May 1984 A
4486176 Tardieu et al. Dec 1984 A
4501266 McDaniel Feb 1985 A
4522501 Shannon Jun 1985 A
4537520 Ochiai et al. Aug 1985 A
4550279 Klein Oct 1985 A
4561798 Elcrin et al. Dec 1985 A
4573454 Hoffman Mar 1986 A
4587850 Moser May 1986 A
4592355 Antebi Jun 1986 A
4595007 Mericle Jun 1986 A
4642257 Chase Feb 1987 A
4658809 Ulrich et al. Apr 1987 A
4700091 Wuthrich Oct 1987 A
4747832 Buffet May 1988 A
4854304 Zielke Aug 1989 A
4904861 Epstein et al. Feb 1990 A
4931055 Bumpus et al. Jun 1990 A
4940467 Tronzo Jul 1990 A
4957495 Kluger Sep 1990 A
4973331 Pursley et al. Nov 1990 A
5010879 Moriya et al. Apr 1991 A
5030235 Campbell, Jr. Jul 1991 A
5041112 Mingozzi et al. Aug 1991 A
5064004 Lundell Nov 1991 A
5074882 Grammont et al. Dec 1991 A
5092889 Campbell, Jr. Mar 1992 A
5133716 Plaza Jul 1992 A
5142407 Varaprasad et al. Aug 1992 A
5156605 Pursley et al. Oct 1992 A
5263955 Baumgart et al. Nov 1993 A
5290289 Sanders et al. Mar 1994 A
5306275 Bryan Apr 1994 A
5330503 Yoon Jul 1994 A
5334202 Carter Aug 1994 A
5336223 Rogers Aug 1994 A
5356411 Spievack Oct 1994 A
5356424 Buzerak et al. Oct 1994 A
5364396 Robinson et al. Nov 1994 A
5403322 Herzenberg et al. Apr 1995 A
5429638 Muschler et al. Jul 1995 A
5437266 McPherson et al. Aug 1995 A
5466261 Richelsoph Nov 1995 A
5468030 Walling Nov 1995 A
5480437 Draenert Jan 1996 A
5509888 Miller Apr 1996 A
5516335 Kummer et al. May 1996 A
5527309 Shelton Jun 1996 A
5536269 Spievack Jul 1996 A
5549610 Russell et al. Aug 1996 A
5573012 McEwan Nov 1996 A
5575790 Chen et al. Nov 1996 A
5582616 Bolduc et al. Dec 1996 A
5620445 Brosnahan et al. Apr 1997 A
5620449 Faccioli et al. Apr 1997 A
5626579 Muschler et al. May 1997 A
5626613 Schmieding May 1997 A
5632744 Campbell, Jr. May 1997 A
5659217 Petersen Aug 1997 A
5662683 Kay Sep 1997 A
5672175 Martin Sep 1997 A
5672177 Seldin Sep 1997 A
5700263 Schendel Dec 1997 A
5704938 Staehlin et al. Jan 1998 A
5704939 Justin Jan 1998 A
5720746 Soubeiran Feb 1998 A
5743910 Bays et al. Apr 1998 A
5762599 Sohn Jun 1998 A
5771903 Jakobsson Jun 1998 A
5810815 Morales Sep 1998 A
5827286 Incavo et al. Oct 1998 A
5830221 Stein et al. Nov 1998 A
5879375 Larson, Jr. et al. Mar 1999 A
5902304 Walker et al. May 1999 A
5935127 Border Aug 1999 A
5945762 Chen et al. Aug 1999 A
5961553 Coty et al. Oct 1999 A
5976138 Baumgart et al. Nov 1999 A
5979456 Magovern Nov 1999 A
6022349 McLeod et al. Feb 2000 A
6033412 Losken et al. Mar 2000 A
6034296 Elvin et al. Mar 2000 A
6102922 Jakobsson et al. Aug 2000 A
6106525 Sachse Aug 2000 A
6126660 Dietz Oct 2000 A
6126661 Faccioli et al. Oct 2000 A
6138681 Chen et al. Oct 2000 A
6139316 Sachdeva et al. Oct 2000 A
6162223 Orsak et al. Dec 2000 A
6183476 Gerhardt et al. Feb 2001 B1
6200317 Aalsma et al. Mar 2001 B1
6234956 He et al. May 2001 B1
6241730 Alby Jun 2001 B1
6245075 Betz et al. Jun 2001 B1
6315784 Djurovic Nov 2001 B1
6319255 Grundei et al. Nov 2001 B1
6331744 Chen et al. Dec 2001 B1
6336929 Justin Jan 2002 B1
6343568 McClasky Feb 2002 B1
6358283 Hogfors et al. Mar 2002 B1
6375682 Fleischmann et al. Apr 2002 B1
6389187 Greenaway et al. May 2002 B1
6400980 Lemelson Jun 2002 B1
6402753 Cole et al. Jun 2002 B1
6409175 Evans et al. Jun 2002 B1
6416516 Stauch et al. Jul 2002 B1
6499907 Baur Dec 2002 B1
6500110 Davey et al. Dec 2002 B1
6508820 Bales Jan 2003 B2
6510345 Van Bentem Jan 2003 B1
6537196 Creighton, IV et al. Mar 2003 B1
6554831 Rivard et al. Apr 2003 B1
6565573 Ferrante et al. May 2003 B1
6565576 Stauch et al. May 2003 B1
6582313 Perrow Jun 2003 B2
6583630 Mendes et al. Jun 2003 B2
6616669 Ogilvie et al. Sep 2003 B2
6626917 Craig Sep 2003 B1
6656135 Zogbi et al. Dec 2003 B2
6656194 Gannoe et al. Dec 2003 B1
6667725 Simons et al. Dec 2003 B1
6673079 Kane Jan 2004 B1
6702816 Buhler Mar 2004 B2
6706042 Taylor Mar 2004 B2
6709293 Mori et al. Mar 2004 B2
6730087 Butsch May 2004 B1
6761503 Breese Jul 2004 B2
6769499 Cargill et al. Aug 2004 B2
6789442 Forch Sep 2004 B2
6796984 Soubeiran Sep 2004 B2
6802844 Ferree Oct 2004 B2
6809434 Duncan et al. Oct 2004 B1
6835207 Zacouto et al. Dec 2004 B2
6852113 Nathanson et al. Feb 2005 B2
6918838 Schwarzler et al. Jul 2005 B2
6918910 Smith et al. Jul 2005 B2
6921400 Sohngen Jul 2005 B2
6923951 Contag et al. Aug 2005 B2
6971143 Domroese Dec 2005 B2
7001346 White Feb 2006 B2
7008425 Phillips Mar 2006 B2
7011658 Young Mar 2006 B2
7029472 Fortin Apr 2006 B1
7029475 Panjabi Apr 2006 B2
7041105 Michelson May 2006 B2
7060080 Bachmann Jun 2006 B2
7063706 Wittenstein Jun 2006 B2
7105029 Doubler et al. Sep 2006 B2
7105968 Nissen Sep 2006 B2
7114501 Johnson et al. Oct 2006 B2
7115129 Heggeness Oct 2006 B2
7135022 Kosashvili et al. Nov 2006 B2
7160312 Saadat Jan 2007 B2
7163538 Altarac et al. Jan 2007 B2
7189005 Ward Mar 2007 B2
7191007 Desai et al. Mar 2007 B2
7218232 DiSilvestro et al. May 2007 B2
7238191 Bachmann Jul 2007 B2
7241300 Sharkawy et al. Jul 2007 B2
7243719 Baron et al. Jul 2007 B2
7245117 Joy et al. Jul 2007 B1
7255682 Bartol, Jr. et al. Aug 2007 B1
7282023 Frering Oct 2007 B2
7285087 Moaddeb et al. Oct 2007 B2
7302015 Kim et al. Nov 2007 B2
7302858 Walsh et al. Dec 2007 B2
7314443 Jordan et al. Jan 2008 B2
7333013 Berger Feb 2008 B2
7357037 Hnat et al. Apr 2008 B2
7357635 Belfor et al. Apr 2008 B2
7360542 Nelson et al. Apr 2008 B2
7390007 Helms et al. Jun 2008 B2
7390294 Hassler, Jr. Jun 2008 B2
7402134 Moaddeb et al. Jul 2008 B2
7402176 Malek Jul 2008 B2
7429259 Cadeddu et al. Sep 2008 B2
7445010 Kugler et al. Nov 2008 B2
7458981 Fielding et al. Dec 2008 B2
7485149 White Feb 2009 B1
7489495 Stevenson Feb 2009 B2
7530981 Kutsenko May 2009 B2
7531002 Sutton et al. May 2009 B2
7553298 Hunt et al. Jun 2009 B2
7561916 Hunt et al. Jul 2009 B2
7611526 Carl et al. Nov 2009 B2
7618435 Opolski Nov 2009 B2
7658754 Zhang et al. Feb 2010 B2
7666184 Stauch Feb 2010 B2
7666210 Franck et al. Feb 2010 B2
7678136 Doubler et al. Mar 2010 B2
7678139 Garamszegi et al. Mar 2010 B2
7708737 Kraft et al. May 2010 B2
7708762 McCarthy et al. May 2010 B2
7727143 Birk et al. Jun 2010 B2
7753913 Szakelyhidi, Jr. et al. Jul 2010 B2
7753915 Eksler et al. Jul 2010 B1
7762998 Birk et al. Jul 2010 B2
7763080 Southworth Jul 2010 B2
7766855 Miethke Aug 2010 B2
7775215 Hassler, Jr. et al. Aug 2010 B2
7776068 Ainsworth et al. Aug 2010 B2
7776075 Bruneau et al. Aug 2010 B2
7787958 Stevenson Aug 2010 B2
7794476 Wisnewski Sep 2010 B2
7811328 Molz, IV et al. Oct 2010 B2
7835779 Anderson et al. Nov 2010 B2
7837691 Cordes et al. Nov 2010 B2
7862586 Malek Jan 2011 B2
7867235 Fell et al. Jan 2011 B2
7875033 Richter et al. Jan 2011 B2
7901381 Birk et al. Mar 2011 B2
7909852 Boomer et al. Mar 2011 B2
7918844 Byrum et al. Apr 2011 B2
7938841 Sharkawy et al. May 2011 B2
7985256 Grotz et al. Jul 2011 B2
7988709 Clark et al. Aug 2011 B2
8002809 Baynham Aug 2011 B2
8011308 Picchio Sep 2011 B2
8034080 Malandain et al. Oct 2011 B2
8043299 Conway Oct 2011 B2
8043338 Dant Oct 2011 B2
8057473 Orsak et al. Nov 2011 B2
8057513 Kohm et al. Nov 2011 B2
8083741 Morgan et al. Dec 2011 B2
8092499 Roth Jan 2012 B1
8095317 Ekseth et al. Jan 2012 B2
8105360 Connor Jan 2012 B1
8114158 Carl et al. Feb 2012 B2
8123805 Makower et al. Feb 2012 B2
8133280 Voellmicke et al. Mar 2012 B2
8147549 Metcalf, Jr. et al. Apr 2012 B2
8162897 Byrum Apr 2012 B2
8162979 Sachs et al. Apr 2012 B2
8177789 Magill et al. May 2012 B2
8197490 Pool et al. Jun 2012 B2
8211149 Justis Jul 2012 B2
8211151 Schwab et al. Jul 2012 B2
8221420 Keller Jul 2012 B2
8226690 Altarac et al. Jul 2012 B2
8236002 Fortin et al. Aug 2012 B2
8241331 Arnin Aug 2012 B2
8246630 Manzi et al. Aug 2012 B2
8252063 Stauch Aug 2012 B2
8267969 Altarac et al. Sep 2012 B2
8278941 Kroh et al. Oct 2012 B2
8282671 Connor Oct 2012 B2
8323290 Metzger et al. Dec 2012 B2
8357182 Seme Jan 2013 B2
8366628 Denker et al. Feb 2013 B2
8372078 Collazo Feb 2013 B2
8386018 Stauch et al. Feb 2013 B2
8394124 Biyani Mar 2013 B2
8403958 Schwab Mar 2013 B2
8414584 Brigido Apr 2013 B2
8425608 Dewey et al. Apr 2013 B2
8435268 Thompson et al. May 2013 B2
8439926 Bojarski et al. May 2013 B2
8444693 Reiley May 2013 B2
8469908 Asfora Jun 2013 B2
8470004 Reiley Jun 2013 B2
8486070 Morgan et al. Jul 2013 B2
8486076 Chavarria et al. Jul 2013 B2
8486147 De Villiers et al. Jul 2013 B2
8494805 Roche et al. Jul 2013 B2
8496662 Novak et al. Jul 2013 B2
8518062 Cole et al. Aug 2013 B2
8523866 Sidebotham et al. Sep 2013 B2
8529474 Gupta et al. Sep 2013 B2
8529606 Alamin et al. Sep 2013 B2
8529607 Alamin et al. Sep 2013 B2
8556901 Anthony et al. Oct 2013 B2
8556911 Mehta et al. Oct 2013 B2
8556975 Ciupik et al. Oct 2013 B2
8562653 Alamin et al. Oct 2013 B2
8568457 Hunziker Oct 2013 B2
8617220 Skaggs Oct 2013 B2
8579979 Edie et al. Nov 2013 B2
8585595 Heilman Nov 2013 B2
8585740 Ross et al. Nov 2013 B1
8591549 Lange Nov 2013 B2
8591553 Eisermann et al. Nov 2013 B2
8613758 Linares Dec 2013 B2
8623036 Harrison et al. Jan 2014 B2
8632544 Haaja et al. Jan 2014 B2
8632548 Soubeiran Jan 2014 B2
8632563 Nagase et al. Jan 2014 B2
8636771 Butler et al. Jan 2014 B2
8636802 Serhan et al. Jan 2014 B2
8641719 Gephart et al. Feb 2014 B2
8641723 Connor Feb 2014 B2
8657856 Gephart et al. Feb 2014 B2
8663285 Dall et al. Mar 2014 B2
8663287 Butler et al. Mar 2014 B2
8668719 Alamin et al. Mar 2014 B2
8709090 Makower et al. Apr 2014 B2
8758347 Weiner et al. Jun 2014 B2
8758355 Fisher et al. Jun 2014 B2
8771272 LeCronier et al. Jul 2014 B2
8777947 Zahrly et al. Jul 2014 B2
8777995 McClintock et al. Jul 2014 B2
8790343 McClellan et al. Jul 2014 B2
8790409 Van den Heuvel et al. Jul 2014 B2
8828058 Elsebaie et al. Sep 2014 B2
8828087 Stone et al. Sep 2014 B2
8840651 Reiley Sep 2014 B2
8870881 Rezach et al. Oct 2014 B2
8870959 Arnin Oct 2014 B2
8915915 Harrison et al. Dec 2014 B2
8915917 Doherty et al. Dec 2014 B2
8920422 Homeier et al. Dec 2014 B2
8945188 Rezach et al. Feb 2015 B2
8961521 Keefer et al. Feb 2015 B2
8961567 Hunziker Feb 2015 B2
8968402 Myers et al. Mar 2015 B2
8992527 Guichet Mar 2015 B2
9022917 Kasic et al. May 2015 B2
9044218 Young Jun 2015 B2
9060810 Kercher et al. Jun 2015 B2
9078703 Arnin Jul 2015 B2
20020050112 Koch et al. May 2002 A1
20020072758 Reo et al. Jun 2002 A1
20020164905 Bryant Nov 2002 A1
20030040671 Somogyi et al. Feb 2003 A1
20030097064 Talpade et al. May 2003 A1
20030144669 Robinson Jul 2003 A1
20030220643 Ferree Nov 2003 A1
20030220644 Thelen et al. Nov 2003 A1
20040011137 Hnat et al. Jan 2004 A1
20040011365 Govari et al. Jan 2004 A1
20040019353 Freid et al. Jan 2004 A1
20040023623 Stauch et al. Feb 2004 A1
20040055610 Forsell Mar 2004 A1
20040133219 Forsell Jul 2004 A1
20040138663 Kosashvili et al. Jul 2004 A1
20040138725 Forsell Jul 2004 A1
20040193266 Meyer Sep 2004 A1
20050034705 McClendon Feb 2005 A1
20050049617 Chatlynne et al. Mar 2005 A1
20050065529 Liu et al. Mar 2005 A1
20050090823 Bartimus Apr 2005 A1
20050159754 Odrich Jul 2005 A1
20050234448 McCarthy Oct 2005 A1
20050234462 Hershberger Oct 2005 A1
20050246034 Soubeiran Nov 2005 A1
20050261779 Meyer Nov 2005 A1
20050272976 Tanaka et al. Dec 2005 A1
20060004459 Hazebrouck et al. Jan 2006 A1
20060009767 Kiester Jan 2006 A1
20060036259 Carl et al. Feb 2006 A1
20060036323 Carl et al. Feb 2006 A1
20060036324 Sachs et al. Feb 2006 A1
20060047282 Gordon Mar 2006 A1
20060058792 Hynes Mar 2006 A1
20060069447 DiSilvestro et al. Mar 2006 A1
20060074448 Harrison et al. Apr 2006 A1
20060079897 Harrison et al. Apr 2006 A1
20060136062 DiNello et al. Jun 2006 A1
20060142767 Green et al. Jun 2006 A1
20060155279 Ogilvie Jul 2006 A1
20060195087 Sacher et al. Aug 2006 A1
20060195088 Sacher et al. Aug 2006 A1
20060200134 Freid et al. Sep 2006 A1
20060204156 Takehara et al. Sep 2006 A1
20060235299 Martinelli Oct 2006 A1
20060235424 Vitale et al. Oct 2006 A1
20060241746 Shaoulian et al. Oct 2006 A1
20060241767 Doty Oct 2006 A1
20060249914 Dulin Nov 2006 A1
20060271107 Harrison et al. Nov 2006 A1
20060282073 Simanovsky Dec 2006 A1
20060287602 O'Brien et al. Dec 2006 A1
20060293683 Stauch Dec 2006 A1
20070010814 Stauch Jan 2007 A1
20070010887 Williams et al. Jan 2007 A1
20070021644 Woolson et al. Jan 2007 A1
20070031131 Griffitts Feb 2007 A1
20070043376 Leatherbury et al. Feb 2007 A1
20070050030 Kim Mar 2007 A1
20070118215 Moaddeb May 2007 A1
20070161984 Cresina et al. Jul 2007 A1
20070173837 Chan et al. Jul 2007 A1
20070179493 Kim Aug 2007 A1
20070185374 Kick et al. Aug 2007 A1
20070233098 Mastrorio et al. Oct 2007 A1
20070239159 Altarac et al. Oct 2007 A1
20070239161 Giger et al. Oct 2007 A1
20070255088 Jacobson et al. Nov 2007 A1
20070270803 Giger et al. Nov 2007 A1
20070276368 Trieu et al. Nov 2007 A1
20070276369 Allard et al. Nov 2007 A1
20070276373 Malandain Nov 2007 A1
20070276378 Harrison et al. Nov 2007 A1
20070276493 Malandain et al. Nov 2007 A1
20070288024 Gollogly Dec 2007 A1
20070288183 Bulkes et al. Dec 2007 A1
20080009792 Henniges et al. Jan 2008 A1
20080015577 Loeb Jan 2008 A1
20080021454 Chao et al. Jan 2008 A1
20080021455 Chao et al. Jan 2008 A1
20080021456 Gupta et al. Jan 2008 A1
20080027436 Cournoyer et al. Jan 2008 A1
20080033431 Jung et al. Feb 2008 A1
20080033436 Song et al. Feb 2008 A1
20080051784 Gollogly Feb 2008 A1
20080082118 Edidin et al. Apr 2008 A1
20080086128 Lewis Apr 2008 A1
20080097487 Pool et al. Apr 2008 A1
20080097496 Chang et al. Apr 2008 A1
20080108995 Conway et al. May 2008 A1
20080161933 Grotz et al. Jul 2008 A1
20080167685 Allard et al. Jul 2008 A1
20080172063 Taylor Jul 2008 A1
20080177319 Schwab Jul 2008 A1
20080177326 Thompson Jul 2008 A1
20080190237 Radinger et al. Aug 2008 A1
20080228186 Gall et al. Sep 2008 A1
20080255615 Vittur et al. Oct 2008 A1
20080272928 Shuster Nov 2008 A1
20080275557 Makower et al. Nov 2008 A1
20090030462 Buttermann Jan 2009 A1
20090076597 Dahlgren et al. Mar 2009 A1
20090082815 Zylber et al. Mar 2009 A1
20090088803 Justis et al. Apr 2009 A1
20090093820 Trieu et al. Apr 2009 A1
20090093890 Gelbart Apr 2009 A1
20090112263 Pool et al. Apr 2009 A1
20090163780 Tieu Jun 2009 A1
20090171356 Klett Jul 2009 A1
20090192514 Feinberg et al. Jul 2009 A1
20090198144 Phillips et al. Aug 2009 A1
20090216113 Meier et al. Aug 2009 A1
20090275984 Kim et al. Nov 2009 A1
20100004654 Schmitz et al. Jan 2010 A1
20100057127 McGuire et al. Mar 2010 A1
20100094302 Pool et al. Apr 2010 A1
20100094306 Chang et al. Apr 2010 A1
20100100185 Trieu et al. Apr 2010 A1
20100106192 Barry Apr 2010 A1
20100114322 Clifford et al. May 2010 A1
20100130941 Conlon et al. May 2010 A1
20100137872 Kam et al. Jun 2010 A1
20100145449 Makower et al. Jun 2010 A1
20100145462 Ainsworth et al. Jun 2010 A1
20100168751 Anderson et al. Jul 2010 A1
20100249782 Durham Sep 2010 A1
20100256626 Muller et al. Oct 2010 A1
20100262239 Boyden et al. Oct 2010 A1
20100318129 Seme et al. Dec 2010 A1
20100331883 Schmitz et al. Dec 2010 A1
20110004076 Janna et al. Jan 2011 A1
20110057756 Marinescu et al. Mar 2011 A1
20110066188 Seme et al. Mar 2011 A1
20110098748 Jangra Apr 2011 A1
20110152725 Demir et al. Jun 2011 A1
20110196435 Forsell Aug 2011 A1
20110202138 Shenoy et al. Aug 2011 A1
20110238126 Soubeiran Sep 2011 A1
20110257655 Copf, Jr. Oct 2011 A1
20110284014 Cadeddu et al. Nov 2011 A1
20120019341 Gabay et al. Jan 2012 A1
20120019342 Gabay et al. Jan 2012 A1
20120053633 Stauch Mar 2012 A1
20120088953 King Apr 2012 A1
20120109207 Trieu May 2012 A1
20120116535 Ratron et al. May 2012 A1
20120158061 Koch et al. Jun 2012 A1
20120172883 Sayago Jul 2012 A1
20120179215 Soubeiran Jul 2012 A1
20120221106 Makower et al. Aug 2012 A1
20120271353 Barry Oct 2012 A1
20120296234 Wilhelm et al. Nov 2012 A1
20120329882 Messersmith et al. Dec 2012 A1
20130013066 Landry et al. Jan 2013 A1
20130072932 Stauch Mar 2013 A1
20130123847 Anderson et al. May 2013 A1
20130138017 Jundt et al. May 2013 A1
20130138154 Reiley May 2013 A1
20130150863 Baumgartner Jun 2013 A1
20130150889 Fening et al. Jun 2013 A1
20130178903 Abdou Jul 2013 A1
20130211521 Shenoy et al. Aug 2013 A1
20130245692 Hayes et al. Sep 2013 A1
20130253344 Griswold et al. Sep 2013 A1
20130253587 Carls et al. Sep 2013 A1
20130261672 Horvath Oct 2013 A1
20130296863 Globerman et al. Nov 2013 A1
20130296864 Burley et al. Nov 2013 A1
20130296940 Northcutt et al. Nov 2013 A1
20130325006 Michelinie et al. Dec 2013 A1
20130325071 Niemiec et al. Dec 2013 A1
20140005788 Haaja et al. Jan 2014 A1
20140025172 Lucas et al. Jan 2014 A1
20140052134 Orisek Feb 2014 A1
20140058392 Mueckter et al. Feb 2014 A1
20140058450 Arlet Feb 2014 A1
20140066987 Hestad et al. Mar 2014 A1
20140088715 Ciupik Mar 2014 A1
20140128920 Kantelhardt May 2014 A1
20140163664 Goldsmith Jun 2014 A1
20140236234 Kroll et al. Aug 2014 A1
20140236311 Vicatos et al. Aug 2014 A1
20140257412 Patty et al. Sep 2014 A1
20140277446 Clifford et al. Sep 2014 A1
20140296918 Fening et al. Oct 2014 A1
20140303538 Baym et al. Oct 2014 A1
20140303539 Baym et al. Oct 2014 A1
20140358150 Kaufman et al. Dec 2014 A1
20150105782 D'Lima et al. Apr 2015 A1
20150105824 Moskowitz et al. Apr 2015 A1
Foreign Referenced Citations (29)
Number Date Country
1697630 Nov 2005 CN
101040807 Sep 2007 CN
1541262 Jun 1969 DE
8515687 Dec 1985 DE
19626230 Jan 1998 DE
19745654 Apr 1999 DE
102005045070 Apr 2007 DE
0663184 Jul 1995 EP
1905388 Apr 2008 EP
2901991 Dec 2007 FR
2900563 Aug 2008 FR
2892617 Sep 2008 FR
2916622 Sep 2009 FR
2961386 Jul 2012 FR
H0956736 Mar 1997 JP
2002500063 Jan 2002 JP
WO1998044858 Jan 2002 WO
WO1999051160 Jan 2002 WO
WO2001024697 Jan 2002 WO
WO2001045485 Jan 2002 WO
WO2001045487 Jan 2002 WO
WO2001067973 Jan 2002 WO
WO2001078614 Jan 2002 WO
2004075727 Sep 2004 WO
WO2007015239 Jan 2008 WO
WO2007013059 Apr 2009 WO
WO2011116158 Jan 2012 WO
WO2013119528 Aug 2013 WO
WO2014040013 Mar 2014 WO
Non-Patent Literature Citations (103)
Entry
International Search Report for PCT/US2012/058499, ISA, dated Feb. 20, 2013, pp. 3.
Abe et al., “Experimental external fixation combined with percutaneous discectomy in the management of scoliosis.”, SPINE, 1999, pp. 646-653, 24, No. 7.
Ahlbom et al., “Guidelines for limiting exposure to time-varying electric, magnetic, and electromagnetic fields (up to 300 GHz). International Commission on Non-Ionizing Radiation Protection.”, Health Physics, 1998, pp. 494-522, 74, No. 4.
Amer et al., “Evaluation of treatment of late-onset tibia vara using gradual angulation translation high tibial osteotomy”, ACTA Orthopaedica Belgica, 2010, pp. 360-366, 76, No. 3.
Angrisani et al., “Lap-Band® Rapid Port™ System: Preliminary results in 21 patients”, Obesity Surgery, 2005, p. 936, 15, No. 7.
Baumgart et al., “A fully implantable, programmable distraction nail (Fitbone)—new perspectives for corrective and reconstructive limb surgery.”, Practice of Intramedullary Locked Nails, 2006, pp. 189-198.
Baumgart et al., “The bioexpandable prosthesis: A new perspective after resection of malignant bone tumors in children.”, J Pediatr Hematol Oncol, 2005, pp. 452-455, 27, No. 8.
Bodó et al., “Development of a tension-adjustable implant for anterior cruciate ligament reconstruction.”, Eklem Hastaliklari ve Cerrahisi—Joint Diseases and Related Surgery, 2008, pp. 27-32, 19, No. 1.
Boudjemline et al., “Off-label use of an adjustable gastric banding system for pulmonary artery banding.”, The Journal of Thoracic and Cardiovascular Surgery, 2006, pp. 1130-1135, 131, No. 5.
Brown et al., “Single port surgery and the Dundee Endocone.”, SAGES Annual Scientific Sessions: Emerging Technology Poster Abstracts, 2007, ETP007, pp. 323-324.
Buchowski et al., “Temporary internal distraction as an aid to correction of severe scoliosis”, J Bone Joint Surg Am, 2006, pp. 2035-2041, 88-A, No. 9.
Burghardt et al., “Mechanical failure of the Intramedullary Skeletal Kinetic Distractor in limb lengthening.”, J Bone Joint Surg Br, 2011, pp. 639-643, 93-B, No. 5.
Burke, “Design of a minimally invasive non fusion device for the surgical management of scoliosis in the skeletally immature”, Studies in Health Technology and Informatics, 2006, pp. 378-384, 123.
Carter et al., “A cumulative damage model for bone fracture.”, Journal of Orthopaedic Research, 1985, pp. 84-90, 3, No. 1.
Chapman et al., “Laparoscopic adjustable gastric banding in the treatment of obesity: A systematic literature review.”, Surgery, 2004, pp. 326-351, 135, No. 3.
Cole et al., “Operative technique intramedullary skeletal kinetic distractor: Tibial surgical technique.”, Ortho fix, 2005.
Cole et al., “The intramedullary skeletal kinetic distractor (ISKD): first clinical results of a new intramedullary nail for lengthening of the femur and tibia.”, Injury, 2001, pp. S-D-129-S-D-139, 32.
Dailey et al., “A novel intramedullary nail for micromotion stimulation of tibial fractures.”, Clinical Biomechanics, 2012, pp. 182-188, 27, No. 2.
Daniels et al., “A new method for continuous intraoperative measurement of Harrington rod loading patterns.”, Annals of Biomedical Engineering, 1984, pp. 233-246, 12, No. 3.
De Giorgi et al., “Cotrel-Dubousset instrumentation for the treatment of severe scoliosis.”, European Spine Journal, 1999, pp. 8-15, No. 1.
Dorsey et al., “The stability of three commercially available implants used in medial opening wedge high tibial osteotomy.”, Journal of Knee Surgery, 2006, pp. 95-98, 19, No. 2.
Edeland et al., “Instrumentation for distraction by limited surgery in scoliosis treatment.”, Journal of Biomedical Engineering, 1981, pp. 143-146, 3, No. 2.
Elsebaie, “Single growing rods (Review of 21 cases). Changing the foundations: Does it affect the results?”, Journal of Child Orthop, 2007, 1:258.
Ember et al., “Distraction forces required during growth rod lengthening.”, J of Bone Joint Surg BR, 2006, p. 229, 88-B, No. Suppl. II.
European Patent Office, “Observations by a third party under Article 115 EPC in EP08805612 by Soubeiran.”, 2010.
Fabry et al., “A technique for prevention of port complications after laparoscopic adjustable silicone gastric banding.”, Obesity Surgery, 2002, pp. 285-288, 12, No. 2.
Fried et al., “In vivo measurements of different gastric band pressures towards the gastric wall at the stoma region.”, Obesity Surgery, 2004, p. 914, 14, No. 7.
Gao et al., CHD7 gene polymorphisms are associated with susceptibility to idiopathic scoliosis, American Journal of Human Genetics, 2007, pp. 957-965, 80.
Gebhart et al., “Early clinical experience with a custom made growing endoprosthesis in children with malignant bone tumors of the lower extremity actioned by an external permanent magnet; The Phenix M. system”, International Society of Limb Salvage 14th International Symposium on Limb Salvage. Sep. 3, 2007, Hamburg, Germany. (2 pages).
Gillespie et al. “Harrington instrumentation without fusion.”, J Bone Joint Surg Br, 1981, p. 461, 63-B, No. 3.
Goodship et al., “Strain rate and timing of stimulation in mechanical modulation of fracture healing.”, Clinical Orthopaedics and Related Research, 1998, pp. S105-S115, No. 355S.
Grass et al., “Intermittent distracting rod for correction of high neurologic risk congenital scoliosis.”, SPINE, 1997, pp. 1922-1927, 22, No. 16.
Gray, “Gray's anatomy of the human body.”, http://education.yahoo.com/reference/gray/subjects/subject/128, published Jul. 1, 2007.
Grimer et al. “Non-invasive extendable endoprostheses for children—Expensive but worth it!”, International Society of Limb Salvage 14th International Symposium on Limb Salvage, 2007.
Grünert, “The development of a totally implantable electronic sphincter.” (translated from the German “Die Entwicklung eines total implantierbaren elektronischen Sphincters”), Langenbecks Archiv fur Chirurgie, 1969, pp. 1170-1174, 325.
Guichet et al. “Gradual femoral lengthening with the Albizzia intramedullary nail”, J Bone Joint Surg Am, 2003, pp. 838-848, 85-A, No. 5.
Gupta et al., “Non-invasive distal femoral expandable endoprosthesis for limb-salvage surgery in paediatric tumours.”, J Bone Joint Surg Br, 2006, pp. 649-654, 88-B, No. 5.
Hankemeier et al., “Limb lengthening with the Intramedullary Skeletal Kinetic Distractor (ISKD).”, Oper Orthop Traumatol, 2005, pp. 79-101, 17, No. 1.
Harbach et al., “First experiences with the routine use of the Rapid Port™ system with the Lap-Band®.”, Obesity Surgery, 2006, p. 418, 16, No. 4.
Harrington, “Treatment of scoliosis. Correction and internal fixation by spine instrumentation.”, J Bone Joint Surg Am, 1962, pp. 591-610, 44-A, No. 4.
Hennig et al., “The safety and efficacy of a new adjustable plate used for proximal tibial opening wedge osteotomy in the treatment of unicompartmental knee osteoarthrosis.”, Journal of Knee Surgery, 2007, pp. 6-14, 20, No. 1.
Hofmeister et al., “Callus distraction with the Albizzia nail.”, Practice of Intramedullary Locked Nails, 2006, pp. 211-215.
Hyodo et al., “Bone transport using intramedullary fixation and a single flexible traction cable.”, Clinical Orthopaedics and Related Research, 1996, pp. 256-268, 325.
International Commission on Non-Ionizing Radiation Protection, “Guidelines on limits of exposure to static magnetic fields.” Health Physics, 2009, pp. 504-514, 96, No. 4.
INVIS®/Lamello Catalog, 2006, Article No. 68906A001 GB.
Kasliwal et al., “Management of high-grade spondylolisthesis.”, Neurosurgery Clinics of North America, 2013, pp. 275-291, 24, No. 2.
Kenawey et al., “Leg lengthening using intramedullay skeletal kinetic distractor: Results of 57 consecutive applications.”, Injury, 2011, pp. 150-155, 42, No. 2.
Kent et al., “Assessment and correction of femoral mahotation following intramedullary nailing of the femur.”, Acta Orthop Belg, 2010, pp. 580-584, 76, No. 5.
Klemme et al., “Spinal instrumentation without fusion for progressive scoliosis in young children”, Journal of Pediatric Orthopaedics. 1997, pp. 734-742, 17, No. 6.
Korenkov et al., “Port function after laparoscopic adjustable gastric banding for morbid obesity.”, Surgical Endoscopy, 2003, pp. 1068-1071, 17, No. 7.
Krieg et al., “Leg lengthening with a motorized nail in adolescents.”, Clinical Orthopaedics and Related Research, 2008, pp. 189-197, 466, No. 1.
Kucukkaya et al., “The new intramedullary cable bone transport technique.”, Journal of Orthopaedic Trauma, 2009, pp. 531-536, 23, No. 7.
Lechner et al., “In vivo band manometry: A new method in band adjustment”, Obesity Surgery, 2005, p. 935, 15, No. 7.
Lechner et al., “Intra-band manometry for band adjustments: The basics”, Obesity Surgery, 2006, pp. 417-418, 16, No. 4.
Li et al., “Bone transport over an intramedullary nail: A case report with histologic examination of the regenerated segment.”, Injury, 1999, pp. 525-534, 30, No. 8.
Lonner, “Emerging minimally invasive technologies for the management of scoliosis.”, Orthopedic Clinics of North America, 2007, pp. 431-440, 38, No. 3.
Matthews et al., “Magnetically adjustable intraocular lens.”, Journal of Cataract and Refractive Surgery, 2003, pp. 2211-2216, 29, No. 11.
Micromotion, “Micro Drive Engineering-General catalogue.”, 2009, pp. 14-24.
Mineiro et al., “Subcutaneous rodding for progressive spinal curvatures: Early results.”, Journal of Pediatric Orthopaedics, 2002, pp. 290-295, 22, No. 3.
Moe et al., “Harrington instrumentation without fusion plus external orthotic support for the treatment of difficult curvature problems in young children.”, Clinical Orthopaedics and Related Research, 1984, pp. 35-45, 185.
Montague et al., “Magnetic gear dynamics for servo control.”, Melecon 2010—2010 15th IEEE Mediterranean Electrotechnical Conference, Valletta, 2010, pp. 1192-1197.
Montague et al., “Servo control of magnetic gears.”, IEEE/ASME Transactions on Mechatronics, 2012, pp. 269-278, 17, No. 2.
Nachemson et al., “Intravital wireless telemetry of axial forces in Harrington distraction rods in patients with idiopathic scoliosis.”, The Journal of Bone and Joint Surgery, 1971, pp. 445-465, 53, No. 3.
Nachlas et al., “The cure of experimental scoliosis by directed growth control.”, The Journal of Bone and Joint Surgery, 1951, pp. 24-34, 33-A, No. 1.
Newton et al., “Fusionless scoliosis correction by anterolateral tethering . . . can it work?.”, 39th Annual Scoliosis Research Society Meeting, 2004.
Oh et al., “Bone transport over an intramedullary nail for reconstruction of long bone defects in tibia.”, Archives of Orthopaedic and Trauma Surgery, 2008, pp. 801-808, 128, No. 8.
Ozcivici et al., “Mechanical signals as anabolic agents in bone.”, Nature Reviews Rheumatology, 2010, pp. 50-59, 6, No. 1.
Piorkowski et al., Preventing Port Site Inversion in Laparoscopic Adjustable Gastric Banding, Surgery for Obesity and Related Diseases, 2007, 3(2), pp. 159-162, Elsevier; New York, U.S.A.
Prontes, “Longest bone in body.”, eHow.com, 2012.
Rathjen et al., “Clinical and radiographic results after implant removal in idiopathic scoliosis.”, SPINE, 2007, pp. 2184-2188, 32, No. 20.
Ren et al., “Laparoscopic adjustable gastric banding: Surgical technique”, Journal of Laparoendoscopic & Advanced Surgical Techniques, 2003, pp. 257-263, 13, No. 4.
Reyes-Sanchez et al., “External fixation for dynamic correction of severe scoliosis”, The Spine Journal, 2005, pp. 418-426, 5, No. 4.
Rinsky et al., “Segmental instrumentation without fusion in children with progressive scoliosis.”, Journal of Pediatric Orthopedics, 1985, pp. 687-690, 5, No. 6.
Rode et al., “A simple way to adjust bands under radiologic control”, Obesity Surgery, 2006, p. 418, 16, No. 4.
Schmerling et al., “Using the shape recovery of nitinol in the Harrington rod treatment of scoliosis.”, Journal of Biomedical Materials Research, 1976, pp. 879-892, 10, No. 6.
Scott et al., “Transgastric, transcolonic and transvaginal cholecystectomy using magnetically anchored instruments.”, SAGES Annual Scientific Sessions, Poster Abstracts, Apr. 18-22, 2007, P511, p. 306.
Sharke, “The machinery of life”, Mechanical Engineering Magazine, Feb. 2004, Printed from Internet site Oct. 24, 2007 http://www.memagazine.org/contents/current/features/moflife/moflife.html.
Shiha et al., “Ilizarov gradual correction of genu varum deformity in adults.”, Acta Orthop Belg, 2009, pp. 784-791,75, No. 6.
Simpson et al., “Femoral lengthening with the intramedullary skeletal kinetic distractor.”, Journal of Bone and Joint Surgery, 2009, pp. 955-961, 91-B, No. 7.
Smith, “The use of growth-sparing instrumentation in pediatric spinal deformity.”, Orthopedic Clinics of North America, 2007, pp. 547-552, 38, No. 4.
Soubeiran et al. “The Phenix M System, a fully implanted non-invasive lengthening device externally controllable through the skin with a palm size permanent magnet. Applications in limb salvage.” International Society of Limb Salvage 14th International Symposium on Limb Salvage, Sep. 13, 2007, Hamburg, Germany. (2 pages).
Soubeiran et al., “The Phenix M System. A fully implanted lengthening device externally controllable through the skin with a palm size permanent magnet; Applications to pediatric orthopaedics”, 6th European Research Conference in Pediatric Orthopaedics, Oct. 6, 2006, Toulouse, France (7 pages).
Stokes et al., “Reducing radiation exposure in early-onset scoliosis surgery patients: Novel use of ultrasonography to measure lengthening in magnetically-controlled growing rods. Prospective validation study and assessment of clinical algorithm”, 20th International Meeting on Advanced Spine Techniques, Jul. 11, 2013. Vancouver, Canada. Scoliosis Research Society.
Sun et al., “Masticatory mechanics of a mandibular distraction osteogenesis site: Interfragmentary micromovement.”, Bone, 2007, pp. 188-196, 41, No. 2.
Synthes Spine, “Veptr II. Vertical Expandable Prosthetic Titanium Rib II: Technique Guide.”, 2008, 40 pgs.
Synthes Spine, “VEPTR Vertical Expandable Prosthetic Titanium Rib, Patient Guide.”, 2005, 23 pgs.
Takaso et al., “New remote-controlled growing-rod spinal instrumentation possibly applicable for scoliosis in young children.”, Journal of Orthopaedic Science, 1998, pp. 336-340, 3, No. 6.
Teli et al., “Measurement of forces generated during distraction of growing rods.”, Journal of Children's Orthopaedics, 2007, pp. 257-258, 1, No. 4.
Tello, “Harrington instrumentation without arthrodesis and consecutive distraction program for young children with severe spinal deformities: Experience and technical details.”, The Orthopedic Clinics of North America, 1994, pp. 333-351, 25, No. 2.
Thaller et al., “Limb lengthening with fully implantable magnetically actuated mechanical nails (PHENIX®)—Preliminary results.”, Injury, 2014 (E-published Oct. 28, 2013), pp. S60-S65, 45.
Thompson et al., “Early onset scoliosis: Future directions”, 2007, J Bone Joint Surg Am, pp. 163-166, 89-A, Suppl 1.
Thompson et al., “Growing rod techniques in early-onset scoliosis”, Journal of Pediatric Orthopedics, 2007, pp. 354-361, 27, No. 3.
Thonse et al., “Limb lengthening with a fully implantable, telescopic, intramedullary nail.”, Operative Techniques in Orthopedics, 2005, pp. 355-362, 15, No. 4.
Trias et al., “Dynamic loads experienced in correction of idiopathic scoliosis using two types of Harrington rods.”, SPINE, 1979, pp. 228-235, 4, No. 3.
Verkerke et al., “An extendable modular endoprosthetic system for bone tumor management in the leg”, Journal of Biomedical Engineering, 1990, pp. 91-96, 12, No. 2.
Verkerke et al., “Design of a lengthening element for a modular femur endoprosthetic system”, Proceedings of the Institution of Mechanical Engineers Part H: Journal of Engineering in Medicine, 1989, pp. 97-102, 203, No. 2.
Verkerke et al., “Development and test of an extendable endoprosthesis for bone reconstruction in the leg.”, The International Journal of Artificial Organs, 1994, pp. 155-162, 17, No. 3.
Weiner et al., “Initial clinical experience with telemetrically adjustable gastric banding”, Surgical Technology International, 2005, pp. 63-69, 15.
Wenger, “Spine jack operation in the correction of scoliotic deformity: A direct intrathoracic attack to straighten the laterally bent spine: Preliminary report”, Arch Surg, 1961, pp. 123-132 (901-910), 83, No. 6.
White, III et al., “The clinical biomechanics of scoliosis.”, Clinical Orthopaedics and Related Research, 1976, pp. 100-112, 118.
Yonnet, “A new type of permanent magnet coupling.”, IEEE Transactions on Magnetics, 1981, pp. 2991-2993, 17, No. 6.
Yonnet, “Passive magnetic bearings with permanent magnets.”, IEEE Transactions on Magnetics, 1978, pp. 803-805, 14, No. 5.
Zheng et al., “Force and torque characteristics for magnetically driven blood pump.”, Journal of Magnetism and Magnetic Materials, 2002, pp. 292-302, 241, No. 2.
Related Publications (1)
Number Date Country
20200405187 A1 Dec 2020 US
Continuations (1)
Number Date Country
Parent 13253065 Oct 2011 US
Child 16923733 US